Biosearch Technologies Licenses Genetic Technologies' Non-Coding DNA IP | GenomeWeb
NEW YORK (GenomeWeb News) — Genetic Technologies has licensed certain of its non-coding DNA patents to Biosearch Technologies for research purposes, GTG said today.
 
BTI will use the worldwide license, which includes IP for SNP genotyping and allelic discrimination, to manufacture and distribute oligos, probes, and primers for research use only.
 
All of BTI’s customers will be covered under the GTG patents, GTG said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.